Phase I Trial of Defactinib and VS-6766.
Phase I Trial of Defactinib and VS-6766.
Active, not recruiting · NCT03875820 · Registry updated 2026-03-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase I Trial of Defactinib and VS-6766. | Adnexal Diseases, Carcinoma, Endometrioid, Digestive System Diseases, Digestive System Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, carcinoma, endocrine system disorder, endometrium neoplasm, epithelial neoplasm, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, non-small cell lung carcinoma, ovarian cancer, ovarian disorder, pancreas disorder, pancreatic neoplasm | Active, not recruiting | Phase 1 | 2026-03-10 | NCT03875820 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Institute of Cancer Research, United Kingdom | 59 |
| Verastem, Inc. | 24 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The Christie NHS Foundation Trust | Manchester | United Kingdom | 6 |
| The Newcastle Upon Tyne Hospitals NHS Foundation Trust - Freeman Hospital | Newcastle | United Kingdom | 1 |
| The Royal Marsden NHS Foundation Trust | Sutton | United Kingdom | 21 |
| The Royal Marsden NHS Foundation Trust - Gynecology Unit | Sutton | United Kingdom | 1 |
| The Royal Marsden NHS Foundation Trust - Gynecology Unit | London | United Kingdom | 1 |